Sign in

CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222372868
Phone
(630) 874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Open-market buy Director bought 100,000 shares at $0.15 ($15,380)
  2. 4 Option exercise 10% owner acquired 29,497,027 shares (option exercise)
  3. 4 Open-market sale 10% owner sold 77,100 shares at an average $0.19 ($14,338)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy 10% owner bought 506,292 shares at $0.20 ($101,258)
  7. 3 Insider Initial Statement of Ownership
  8. 4/A Open-market buy 10% owner bought 652,723 shares at an average $0.14 ($91,283)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy 10% owner bought 652,723 shares at an average $0.14 ($91,283)
  11. 4 Open-market buy 10% owner bought 51,000 shares at $0.25 ($12,750)
  12. 4 Open-market buy 10% owner bought 950,623 shares at an average $0.24 ($230,187)
  13. 4 Open-market buy 10% owner bought 998,402 shares at an average $0.26 ($258,606)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy 10% owner bought 694,023 shares at $0.41 ($281,079)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Other disposition 10% owner disposed of 1,388,046 shares (other)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 28 · 560 filings